GOG Partners
Improving Care of Women’s Cancer – TiP of the Iceberg

Activity Overview

The GOG Partners Leadership presents the “GOG-P – Improving Care of Women’s Cancer – TiP of the Iceberg”, An Independent Satellite Symposium during The SGO Annual Virtual Meeting on Women’s Cancer®.  The purpose of this session is to share the evolving and innovative treatment options in ovarian cancer, cervical and endometrial cancers.  This engaging session will introduce the purpose of conducting clinical trials and showcase advancements in treatment regimens, surgical procedures, quality of life analyses, and prevention knowledge.  Our expert leaders will share the emerging data and outline how to integrate these treatments into clinical practice.

Target Audience

The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies.

Learning Objectives

After participating in this activity, participants should be better able to will demonstrate Increased knowledge regarding:

  • The key clinical trial data for newer therapies in advanced ovarian, uterine and cervical cancers.
  • The investigational agents and regimens under evaluation for advanced ovarian, uterine and cervical cancers.
  • Selecting evidence-based therapy for frontline maintenance in advanced ovarian cancer.
  • Understanding immunotherapy-based treatment for patients with endometrial cancer.
  • Increased knowledge regarding the current approaches to advanced cervical cancer care.

Faculty


Dr. Bradley Monk

Dr. Robert Coleman

Dr. Brian Slomovitz

Dr. Leslie Randall

Dr. David O’Malley

Dr. Thomas J. Herzog

Dr. Kathleen N. Moore

Agenda & Presentation Materials

GOG-P – Improving Care of Women’s Cancer – TiP of the Iceberg, An Independent Satellite Symposium during The SGO Annual Virtual Meeting on Women’s Cancer®

Presented on Wednesday, March 24, 2021, 6:45 pm – 8:00 pm CT

6:45 pm – 6:49 pm
Introduction
Bradley J. Monk, MD, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, USA
View presentation
6:49 pm – 6:55 pm
History and Structure of GOG-P
Robert L. Coleman, MD, US Oncology Research, Houston, Texas, USA
View presentation
6:55 pm – 7:13 pm
Current GOG-P clinical trials: Uterine
Brian Slomovitz, MD, Florida International University, Broward Health, Fort Lauderdale, Florida, USA
View presentation
7:13 pm – 7:23 pm
Current GOG-P clinical trials: Cervix
Leslie Randall, MD, VCU Health System, MCV Physicians, Richmond, Virginia, USA
View presentation
7:23 pm – 7:45pm
Current GOG-P clinical trials: Ovarian
David O’Malley, MD, The Ohio State University Medical Center, Columbus, Ohio, USA
View presentation
7:45 pm – 7:51 pm
Investigator Council Overview
Thomas J. Herzog, MD, University of Cincinnati, Cincinnati, Ohio, USA
Kathleen N. Moore, MD, Oklahoma University HSC, Oklahoma City, Oklahoma, USA
View presentation
7:51 pm – 8:00 pm
Future Directions and Discussion
Bradley J. Monk, MD, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, USA
View presentation

Continuing Education

In support of improving patient care, this activity has been planned and implemented by The GOG Foundation, Inc. (GOG).

Accreditation Statement

The GOG Foundation, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

AMA PRA Category 1 Credits™

The GOG Foundation, Inc. designates this on demand activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Method of Participation

There are no fees for participating in and receiving CME credit for this activity. Participants must: 1) read the educational objectives and faculty disclosures; 2) attend the educational activity; 3) email our educational team at info@gog.org to receive and complete the educational evaluation.

Participants who complete the educational activity and evaluation will receive a certificate of credit.

Disclosure Declaration

In compliance with ACCME regulations, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. All reported conflicts are managed by a designated official to ensure a bias-free presentation. Please see the faculty disclosure for detailed information.

Faculty Disclosures
All faculty and planning committee members have no conflicts to disclose:

  • Robert L. Coleman, MD, US Oncology Research, Houston, Texas, USA
  • Bradley J. Monk, MD, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, USA
  • Brian Slomovitz, MD, Florida International University, Broward Health, Fort Lauderdale, Florida, USA
  • Leslie Randall, MD, VCU Health System, MCV Physicians, Richmond, Virginia, USA
  • David O’Malley, MD, The Ohio State University Medical Center, Columbus, Ohio, USA
  • Thomas J. Herzog, MD, University of Cincinnati, Cincinnati, Ohio, USA
  • Kathleen N. Moore, MD, Oklahoma University HSC, Oklahoma City, Oklahoma, USA

Technical Requirements

This on demand activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.